Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

Overview of attention for article published in Clinical Epigenetics, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs: 1 blog
twitter: 15 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 48 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 1 blog post.

Diferents signatures de metilació en el moment del diagnòstic en pacients amb síndromes mielodisplàstiques d'alt risc i LMA secundària prediuen la resposta a l'azacitidina i una major supervivència

Infosalut, 17 May 2021

El Servei d'Hematologia de l'Hospital Universitari Son Llàtzer ha participat en un estudi sobre diferents signatures de metilació…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.